SecBot SecBot
SECBOTREPLAY Home › Report › LH

LH · Labcorp held its 2026 Investor Day, reaffirming full-year 2026 guidance…

LABCORP HOLDINGS INC. · 8-K filed Sep 10, 2026 at 16:47 ET

At the news

NEUTRALIMPACT 5/10

8-K filed Sep 10, 2026 at 16:47 ET

Labcorp held its 2026 Investor Day, reaffirming full-year 2026 guidance and providing a long-term outlook through 2029. The company targets 5%-8% compound annual revenue growth and 8.5%-11.5% adjusted EPS CAGR, driven by specialty diagnostics, technology, and M&A. The filing is a routine strategic update with no new financial data beyond previously issued guidance.

  • Reaffirmed FY2026 guidance: Enterprise revenue $14.71B-$14.83B (+5.4% to +6.3% YoY), Adjusted EPS $18.10-$18.55 (+10.1% to +12.8% YoY), Free Cash Flow $1.24B-$1.36B.
  • Long-term outlook (2026-2029): 5%-8% revenue CAGR, 75-150 bps adjusted operating margin expansion by end of 2029, 8.5%-11.5% adjusted EPS CAGR.
  • Organic revenue growth target of 3.5%-5.5% CAGR, with M&A contributing an additional 1.5%-2.5% CAGR.
  • Diagnostics segment revenue grew from $9.4B in 2023 to $11.5B at 2026 guidance midpoint (7% CAGR).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access